- Advertisement -

- Advertisement -

OHIO WEATHER

Browsing Tag

Moderna

Moderna soars on analyst upgrade

Moderna (NASDAQ: MRNA) saw its stock surge 13% after Oppenheimer & Co. (NYSE: OPY) analyst Hartaj Singh upgraded the stock to "outperform" and predicted five product approvals by 2026. This comes despite a dismal 2023 for the…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.